Britannia Life Sciences Inc. (CSE:BLAB)
Canada flag Canada · Delayed Price · Currency is CAD
0.0700
0.00 (0.00%)
Aug 27, 2026, 5:43 PM EST

Britannia Life Sciences Cash Flow Statement

Millions CAD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
16.5414.657.39-4.775.08-15.46
Depreciation & Amortization
0.060.060.06-0.040.160.19
Other Amortization
---0.10.070
Loss (Gain) From Sale of Assets
-0.06-1.67-0.23-0.47-1.39-
Loss (Gain) From Sale of Investments
-16.85-15.81----
Loss (Gain) on Equity Investments
0.011.912.090.960.020
Stock-Based Compensation
---0.231.051.11
Other Operating Activities
-0.21-0.31-11.942.55-2.5716.5
Change in Accounts Receivable
-1.2-0.76-0.090.170.2-0.1
Change in Inventory
--0.180.07--
Change in Accounts Payable
-0.53-1.070.990.3-0.650.62
Change in Income Taxes
0.290.29----
Change in Other Net Operating Assets
-0.03-0.02-0.010.010.04-0.05
Operating Cash Flow
-0.39-1.16-2.622.092.012.8
Operating Cash Flow Growth
---4.15%-28.26%-

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-----0.06-0.09
Cash Acquisitions
----1.1-2.980.74
Sale (Purchase) of Intangibles
-----0.29-
Investment in Securities
6.04-5.25-2.01---
Other Investing Activities
--12.33-0.34--
Investing Cash Flow
6.04-5.2510.32-1.44-3.320.65

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
---0.03-0.12
Long-Term Debt Issued
--1.68-7.981.41
Total Debt Issued
--1.680.037.981.53
Short-Term Debt Repaid
--0.01-0.02--4.96-3.44
Long-Term Debt Repaid
--0.1-1.08-0.09-0.07-0.08
Total Debt Repaid
-0.11-0.11-1.1-0.09-5.03-3.52
Net Debt Issued (Repaid)
-0.11-0.110.58-0.062.95-1.99
Issuance of Common Stock
0.14----0
Other Financing Activities
---1.79-1.91-0.79-0.6
Financing Cash Flow
0.03-0.11-1.21-1.972.16-2.58

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.02-0.010.040.050.13-0.07
Miscellaneous Cash Flow Adjustments
---0--
Net Cash Flow
5.7-6.526.53-1.280.970.8

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-0.39-1.16-2.622.091.952.71
Free Cash Flow Growth
---7.10%-27.99%-
Free Cash Flow Margin
-95.94%-243.50%-709.38%404.71%30.50%37.16%
Free Cash Flow Per Share
-0.00-0.01-0.020.010.010.03
Levered Free Cash Flow
-0.99-1.22-6.885.190.431.79
Unlevered Free Cash Flow
-0.97-1.21-6.825.250.963.24

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
----0.79-
Change in Working Capital
-1.46-1.571.070.55-0.420.46